Quick Answer
Immunocore Holdings plc reported Common Stock Shares Outstanding of 50.69 million shares for the year ending 2025.
- Immunocore Holdings plc showed an increase of +1.2% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Immunocore Holdings plc's annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2022 to 2025), Immunocore Holdings plc's Common Stock Shares Outstanding has grown by 5.4%.
- Historical annual values: Fiscal year 2025: 50.69 million shares | Fiscal year 2024: 50.06 million shares | Fiscal year 2023: 49.73 million shares | Fiscal year 2022: 48.09 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: